Compare ALVO & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALVO | CSR |
|---|---|---|
| Founded | 2013 | 1970 |
| Country | Luxembourg | United States |
| Employees | N/A | 349 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 931.7M |
| IPO Year | 2021 | N/A |
| Metric | ALVO | CSR |
|---|---|---|
| Price | $6.16 | $55.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | $6.80 | ★ $64.14 |
| AVG Volume (30 Days) | ★ 1.1M | 397.5K |
| Earning Date | 11-11-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 5.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.96 | N/A |
| Revenue Next Year | $17.65 | N/A |
| P/E Ratio | ★ $18.20 | $62.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.94 | $52.00 |
| 52 Week High | $9.05 | $69.61 |
| Indicator | ALVO | CSR |
|---|---|---|
| Relative Strength Index (RSI) | 66.45 | 49.17 |
| Support Level | $3.15 | $54.07 |
| Resistance Level | N/A | $57.76 |
| Average True Range (ATR) | 0.34 | 0.97 |
| MACD | -0.02 | -0.19 |
| Stochastic Oscillator | 75.77 | 28.65 |
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.